A five year-old child with clear cell petro-clival meningioma: case report with clinical and histopathological long-term follow-up

被引:11
作者
Juratli, Tareq A. [1 ]
Geiger, Kathrin D. [2 ]
Weigel, Patrick [1 ]
von der Hagen, Maja [3 ]
Daubner, Dirk [4 ]
Pinzer, Thomas [1 ]
Hahn, Gabriele [5 ]
Schackert, Gabriele [1 ]
Kirsch, Matthias [1 ]
机构
[1] Tech Univ Dresden, Med Fak Carl Gustav Carus, Klin & Poliklin Neurochirurg, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Pathol, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Med Fak Carl Gustav Carus, Abt Neuropadiatrie, D-01307 Dresden, Germany
[4] Tech Univ Dresden, Med Fak Carl Gustav Carus, Abt Neuroradiol, D-01307 Dresden, Germany
[5] Tech Univ Dresden, Inst & Poliklin Radiol Diagnost, D-01307 Dresden, Germany
关键词
Clear cell meningioma; Child; Epidermal growth factor receptor; Platelet-derived growth factor receptor; AKT1; mutation; Vascular endothelial growth factor receptor; THERAPY; VARIANT; TUMORS;
D O I
10.1007/s00381-015-2782-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Only a few cases have been previously published about clear cell meningiomas in children, the majority of them in the location of the spine. We describe an unusual case of clear cell meningioma occurring at the petro-clival region in a 5-year-old child. We further seek to determine the impact of several growth factors as well as the AKT1 mutation on the tumor growth pattern. A five-year-old girl was presented with a one-week history of cephalgia, ataxia, and left sided torticollis. Magnetic resonance imaging (MRI) revealed a dumbbell-shaped homogeneously petro-clival gadolinium-enhancing mass. A staged operative approach was chosen, and a complete removal of the tumor was achieved. Due to recurrent tumor progression, the child underwent several tumor surgeries and two cranial radiations. None of the treatments were able to stop tumor progression. Consequently, the child died at the age of 14 after further extensive intracranial and extracranial tumor progression. The initial histological examination revealed a clear cell meningioma WHO grade II with an MIB-1 labeling index of < 1 %, which gradually increased with every recurrence up to 10 % by the last progression at the age of 13 years. Analogically, an increasing overexpression of epidermal growth factor receptor (EGFR), the platelet-derived growth factor receptor (PDGFR), and the vascular endothelial growth factor receptor (VEGFR) was observed with each recurrence. The AKT1 (E17K) mutation in the tumor was not detectable in all investigated specimens. Pediatric clear cell meningiomas WHO grade II are very rare. Our data demonstrate the progressive overexpression of EGF-, PDGF-, and VEGF-receptors in each recurrence, providing one of these receptors as targeted therapy in such cases. Further evaluation of these growth factors in clear cell meningioma is required to establish the optimal treatment of these aggressive tumors.
引用
收藏
页码:2193 / 2198
页数:6
相关论文
共 18 条
[1]   The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma [J].
Chamberlain, Marc C. .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) :666-671
[2]   Intracranial clear cell meningioma: a clinicopathologic study of 15 cases [J].
Chen, Hong ;
Li, Xue-Min ;
Chen, Yuan-Cheng ;
Wu, Jin-Song ;
Dou, Ya-Fang ;
Wang, Yin ;
Xu, Jian ;
Zhong, Ping ;
Jiang, Cheng-Chuan ;
Wang, Xiao-Qiang .
ACTA NEUROCHIRURGICA, 2011, 153 (09) :1769-1780
[3]   Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO [J].
Clark, Victoria E. ;
Erson-Omay, E. Zeynep ;
Serin, Akdes ;
Yin, Jun ;
Cotney, Justin ;
Oezduman, Koray ;
Avsar, Timuin ;
Li, Jie ;
Murray, Phillip B. ;
Henegariu, Octavian ;
Yilmaz, Saliha ;
Guenel, Jennifer Moliterno ;
Carrion-Grant, Geneive ;
Yilmaz, Baran ;
Grady, Conor ;
Tanrikulu, Bahattin ;
Bakircioglu, Mehmet ;
Kaymakcalan, Hande ;
Caglayan, Ahmet Okay ;
Sencar, Leman ;
Ceyhun, Emre ;
Atik, A. Fatih ;
Bayri, Yasar ;
Bai, Hanwen ;
Kolb, Luis E. ;
Hebert, Ryan M. ;
Omay, S. Bulent ;
Mishra-Gorur, Ketu ;
Choi, Murim ;
Overton, John D. ;
Holland, Eric C. ;
Mane, Shrikant ;
State, Matthew W. ;
Bilguevar, Kaya ;
Baehring, Joachim M. ;
Gutin, Philip H. ;
Piepmeier, Joseph M. ;
Vortmeyer, Alexander ;
Brennan, Cameron W. ;
Pamir, M. Necmettin ;
Kilic, Tuerker ;
Lifton, Richard P. ;
Noonan, James P. ;
Yasuno, Katsuhito ;
Guenel, Murat .
SCIENCE, 2013, 339 (6123) :1077-1080
[4]   Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases [J].
Jain, D. ;
Sharma, M. C. ;
Sarkar, C. ;
Suri, V. ;
Garg, A. ;
Singh, M. ;
Sharma, B. S. ;
Mahapatra, A. K. .
JOURNAL OF NEURO-ONCOLOGY, 2007, 81 (03) :315-321
[5]  
Lamszus K, 2000, NEUROSURGERY, V46, P938
[6]  
Lee W, 2000, AM J NEURORADIOL, V21, P130
[7]   Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series [J].
Lou, Emil ;
Sumrall, Ashley L. ;
Turner, Scott ;
Peters, Katherine B. ;
Desjardins, Annick ;
Vredenburgh, James J. ;
McLendon, Roger E. ;
Herndon, James E., II ;
McSherry, Frances ;
Norfleet, Julie ;
Friedman, Henry S. ;
Reardon, David A. .
JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (01) :63-70
[8]   The 2007 WHO classification of tumours of the central nervous system (vol 114, pg 97, 2007) [J].
Louis, David N. ;
Ohgaki, Hiroko ;
Wiestler, Otmar D. ;
Cavenee, Webster K. ;
Burger, Peter C. ;
Jouvet, Anne ;
Scheithauer, Bernd W. ;
Kleihues, Paul .
ACTA NEUROPATHOLOGICA, 2007, 114 (05) :547-547
[9]   Atypical and anaplastic meningiomas treated with bevacizumab [J].
Nayak, Lakshmi ;
Iwamoto, Fabio M. ;
Rudnick, Jeremy D. ;
Norden, Andrew D. ;
Lee, Eudocia Quant ;
Drappatz, Jan ;
Omuro, Antonio ;
Kaley, Thomas J. .
JOURNAL OF NEURO-ONCOLOGY, 2012, 109 (01) :187-193
[10]   Clear Cell Meningioma: A Clinicopathologic Study of 18 Tumors and Examination of the Use of CD10, CA9, and RCC Antibodies to Distinguish Between Clear Cell Meningioma and Metastatic Clear Cell Renal Cell Carcinoma [J].
Prayson, Richard A. ;
Chamberlain, Wendy A. ;
Angelov, Lilyana .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2010, 18 (05) :422-428